Clinical Trial Update: S9804: Vinorelbine in Treating Patients With Stage IV Melanoma [Phase 2]

View source ↗

Summary

SWOG's Phase 2 trial S9804 evaluated vinorelbine in patients with stage IV melanoma; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Navelbine (vinorelbine)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Melanoma (Skin) | Phase 2 | Status: COMPLETED